Logos Global Management’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-400,000
Closed -$12.5M 75
2021
Q3
$12.5M Hold
400,000
0.9% 29
2021
Q2
$11.5M Buy
+400,000
New +$11.5M 0.96% 31